File Download
  Patent History
  • Application
    US 12/4824316 2015-08-12
  • Publication
    US 20160045521 2016-02-18
  Patent Family

published patent: BIOPHOSPHONATE COMPOUNDS AND GAMMA DELTA T CELL-MEDIATED THERAPY FOR TREATING EPSTEIN-BARR VIRUS-ASSOCIATED DISORDERS

TitleBIOPHOSPHONATE COMPOUNDS AND GAMMA DELTA T CELL-MEDIATED THERAPY FOR TREATING EPSTEIN-BARR VIRUS-ASSOCIATED DISORDERS
Priority Date2015-08-12 US 12/4824316
2014-08-12 US 12/2036487P
Inventors
Issue Date2016
Citation
US Published patent application US 20160045521. Washington, DC: US Patent and Trademark Office (USPTO), 2016 How to Cite?
AbstractAminobisphosphonate pamidronate (PAM) can control Epstein-Barr virus (EBV) associated disorders in humanized mice through a V[gamma]9V[delta]2-T-cell dependent mechanism. This suggests a strong potential for a therapeutic approach using PAM to boost human V[gamma]9V[delta]2-T-cell immunity against EBV associated disorders, such as the lymphoproliferative disease (LPD), posttransplant lymphoproliferative disorder (PLPD), Hodgkin's disease, Burkitt's lymphoma, and nasopharyngeal carcinoma (NPC).
Persistent Identifierhttp://hdl.handle.net/10722/225268

 

DC FieldValueLanguage
dc.date.accessioned2016-05-03T05:10:11Z-
dc.date.available2016-05-03T05:10:11Z-
dc.date.issued2016-
dc.identifier.citationUS Published patent application US 20160045521. Washington, DC: US Patent and Trademark Office (USPTO), 2016-
dc.identifier.urihttp://hdl.handle.net/10722/225268-
dc.description.abstractAminobisphosphonate pamidronate (PAM) can control Epstein-Barr virus (EBV) associated disorders in humanized mice through a V[gamma]9V[delta]2-T-cell dependent mechanism. This suggests a strong potential for a therapeutic approach using PAM to boost human V[gamma]9V[delta]2-T-cell immunity against EBV associated disorders, such as the lymphoproliferative disease (LPD), posttransplant lymphoproliferative disorder (PLPD), Hodgkin's disease, Burkitt's lymphoma, and nasopharyngeal carcinoma (NPC).-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documents-
dc.titleBIOPHOSPHONATE COMPOUNDS AND GAMMA DELTA T CELL-MEDIATED THERAPY FOR TREATING EPSTEIN-BARR VIRUS-ASSOCIATED DISORDERS-
dc.typePatent-
dc.identifier.authorityTU WENWEI=rp00416-
dc.identifier.authorityLIU YINPING=rp00269-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorTU WENWEI-
dc.contributor.inventorXIANG ZHENG-
dc.contributor.inventorLIU YINPING-
patents.identifier.applicationUS 12/4824316-
patents.description.assignee UNIV HONG KONG [HK] -
patents.description.countryUnited States of America -
patents.date.publication2016-02-18-
patents.identifier.hkutechidPAED-2014-00536-1-
patents.date.application2015-08-12-
patents.date.priority2015-08-12 US 12/4824316-
patents.date.priority2014-08-12 US 12/2036487P-
patents.description.ccus-
patents.identifier.publicationUS 20160045521-
patents.relation.familyWO 2016023491 (A1) 2016-02-18-
patents.description.kindA1-
patents.typePatent_published-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats